|
Volumn 21, Issue 4, 2009, Pages 265-
|
Can open-label studies demonstrate efficacy in improving sexual function?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALFUZOSIN;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
PLACEBO;
QUINAZOLINE DERIVATIVE;
CLINICAL TRIAL;
DRUG EFFECT;
DRUG EFFICACY;
HUMAN;
LETTER;
MICTURITION;
PRIORITY JOURNAL;
PROSTATE HYPERTROPHY;
QUESTIONNAIRE;
SCORING SYSTEM;
SEXUAL FUNCTION;
URINARY DYSFUNCTION;
ADULT;
DOUBLE BLIND PROCEDURE;
ERECTILE DYSFUNCTION;
MALE;
METHODOLOGY;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
CARDIOVASCULAR DISEASE;
LOWER URINARY TRACT SYMPTOM;
SEXUAL BEHAVIOR;
SEXUAL DYSFUNCTION;
ADRENERGIC ALPHA-ANTAGONISTS;
ADULT;
CLINICAL TRIALS AS TOPIC;
DOUBLE-BLIND METHOD;
ERECTILE DYSFUNCTION;
HUMANS;
MALE;
QUINAZOLINES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RESEARCH DESIGN;
|
EID: 68149166451
PISSN: 09559930
EISSN: 14765489
Source Type: Journal
DOI: 10.1038/ijir.2009.12 Document Type: Letter |
Times cited : (1)
|
References (6)
|